Acetarsol
| Names | |
|---|---|
| Preferred IUPAC name
 (3-Acetamido-4-hydroxyphenyl)arsonic acid  | |
| Other names
 Acetarsone  | |
| Identifiers | |
3D model (JSmol)  | 
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.002.349 | 
| EC Number | 
  | 
| KEGG | |
| MeSH | Acetarsol | 
PubChem CID  | 
|
| UNII | |
| UN number | 3465 | 
CompTox Dashboard (EPA)  | 
|
  | |
  | |
| Properties | |
| C8H10AsNO5 | |
| Molar mass | 275.0903 g mol−1 | 
| Pharmacology | |
| A07AX02 (WHO) G01AB01 (WHO), P01CD02 (WHO), P51AD05 (WHO) | |
| Hazards | |
| GHS labelling: | |
| Danger | |
| H301, H331, H410 | |
| P261, P273, P301+P310, P311, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
Acetarsol (or acetarsone) is an anti-infective drug.
It was first discovered in 1921 at Pasteur Institute by Ernest Fourneau, and sold under the brand name Stovarsol. It has been given in the form of suppositories.
Acetarsol can be used to make arsthinol.
It has been cancelled and withdrawn from the market since August 12th, 1997.